RAF KINASE AND EPIGENETIC REGULATION OF FETAL VASCULAR DEVELOPMENT

RAF 激酶和胎儿血管发育的表观遗传调控

基本信息

  • 批准号:
    9134923
  • 负责人:
  • 金额:
    $ 39.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-11 至 2017-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Raf Kinase and Epigenetic Regulation of Fetal Vascular Development. Project Summary Development of the vasculature is a dynamic process that relies on the coordinated expression of numerous genes. The factors that regulate gene expression during blood vessel development are not well defined, however. Our preliminary data and reports from others of impaired vascular development in B-Raf knockout mice have elucidated the significance of this pathway in the developing vasculature. Importantly, downstream mechanism(s) through which B-Raf regulates vascular development are not known. Based on our preliminary data, we propose that B-Raf kinases via Protein Kinase C (PKC), Signal Transducer and Activator of Transcription 3 (STAT3) and p53 regulate DNA methyl Transferase (DNMT) and Ten-Eleven Translocation Methylcytosine Dioxygenase (TET) gene expression and activities. The altered activities of DNMT and TET lead to changes in promoter DNA methylation resulting in altered expression of genes regulating apoptosis such as Bcl2. These pathways play a crucial role in fetal vascular development. In this project, we will test the hypothesis that B-Raf hypomethylates the Bcl2 promoter to regulate fetal vascular stem cell survival. In the three Specific Aims, we will examine the (1) downstream mediators of B-Raf such as PKC, STAT3, and p53 (2) B-Raf-mediated regulation of DNMT and TET expression and activity, and (3) B-Raf-mediated regulation of promoter DNA methylation of the antiapoptotic gene Bcl2 via DNMT and TET. These studies are highly innovative and significant. Kinase-mediated regulation of epigenetic phenomenon such as DNA methylation is not well studied and is of fundamental importance from a basic science perspective. Moreover, pathways regulating fetal VSC apoptosis are involved in the pathogenesis of several fetal and neonatal disorders such as growth restriction, cerebral palsy, hemangioma, etc. From a clinical perspective, these studies will provide several therapeutic targets to regulate angiogenesis and vascular proliferation in many conditions from organ growth and wound healing to disorders such as myocardial infarction, cerebrovascular accident (stroke), and fetal development in general.
 描述(适用提供):胎儿血管发育的RAF激酶和表观遗传调节。脉管系统的项目摘要开发是一个动态过程,依赖于许多基因的协调表达。但是,调节血管发育过程中基因表达的因素尚未很好地定义。我们的初步数据和其他有关B-RAF敲除小鼠血管发育受损的报告,重要的是,重要的是下游机制,B-RAF调节血管发育尚不清楚。根据我们的初步数据,我们提出了通过蛋白激酶C(PKC),转录3(STAT3)和p53的B-RAF激酶通过蛋白激酶C(PKC),信号传感器和激活剂调节DNA甲基转移酶(DNMT)和十倍易位的甲基胞三糖苷dioxygengenase(Tet)基因表达和活性。 DNMT和TET的活性改变导致启动子DNA甲基化的变化,导致基因调节凋亡(例如BCL2)的表达改变。这些途径在胎儿血管发育中起着至关重要的作用。在该项目中,我们将检验以下假设:B-RAF低甲基甲基甲基启动子调节胎儿血管干细胞的存活。在三个具体目标中,我们将研究B-RAF的(1)下游介质,例如PKC,STAT3和P53(2)B-RAF介导的DNMT和TET表达和活性的调节,以及(3)B-RAF介导的抗蛋白基因BCL 2NMT和TET的抗蛋白基因BCL 2的启动子DNA甲基化的调节。这些研究具有很高的创新性和重要意义。激酶介导的表观遗传现象(例如DNA甲基化)的调节尚未很好地研究,并且从基础科学的角度来看至关重要。此外,从临床角度,这些研究将提供多种治疗靶点,从而在许多治疗范围内,这些研究将提供多种治疗靶点,从而在许多情况下,在许多治疗状态下,在许多治疗状态下,这些研究将提供多种治疗靶点,例如,在许多治疗疾病中,造成了多种疾病的疾病,途径将提供多种治疗靶点,从而,这些研究将提供几种胎儿和新生儿疾病(例如生长限制,脑瘫,血管瘤等)的多种胎儿和新生儿疾病的发病机理。 (中风)和胎儿发育。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Ravi Goyal的其他基金

The role of Alpha1-Adrenergic Receptors Promoter Methylation in Cerebral Autoregulation in Fetus
α1-肾上腺素能受体启动子甲基化在胎儿大脑自动调节中的作用
  • 批准号:
    10657080
    10657080
  • 财政年份:
    2023
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别:
Alpha Adrenergic Methylation and Developmental Maturation of Cerebral Autoregulation in Ovine Preterm Fetus
羊早产儿的α肾上腺素能甲基化和大脑自动调节的发育成熟
  • 批准号:
    10661985
    10661985
  • 财政年份:
    2023
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别:
Modeling and simulation tools for optimizing design of network-informed clinical trials of combination HIV prevention interventions
用于优化 HIV 预防联合干预措施的网络信息临床试验设计的建模和模拟工具
  • 批准号:
    10622168
    10622168
  • 财政年份:
    2022
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别:
Epigenetic Mechanisms of Developmental Regulation of Fetal, Newborn, and Adult Cerebral Artery Sympathetic Innervation and Alpha1 Adrenergic Receptor Subtypes
胎儿、新生儿和成人脑动脉交感神经支配和α1肾上腺素能受体亚型发育调节的表观遗传机制
  • 批准号:
    9237948
    9237948
  • 财政年份:
    2016
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别:
Mechanisms of acclimatization responses of fetal and adult cerebral artery alpha1 adrenergic receptor subtypes to long-term hypoxia
胎儿和成人脑动脉α1肾上腺素能受体亚型对长期缺氧的适应反应机制
  • 批准号:
    9072344
    9072344
  • 财政年份:
    2016
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别:
Cerebral Artery Alpha1 Adrenergic and PKC Regulatory Mechanisms
脑动脉 Alpha1 肾上腺素能和 PKC 调节机制
  • 批准号:
    8811457
    8811457
  • 财政年份:
    2015
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别:
Role of LincRNA in Developmental Regulation of Angiogenesis
LincRNA 在血管生成发育调控中的作用
  • 批准号:
    8768569
    8768569
  • 财政年份:
    2014
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Illuminating adipo-osteoprogenitors in the bone marrow
照亮骨髓中的脂肪骨祖细胞
  • 批准号:
    10590788
    10590788
  • 财政年份:
    2023
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别:
Hox-Regulated MSCs in Skeletal Development, Growth and Fracture Healing
Hox 调节的 MSC 在骨骼发育、生长和骨折愈合中的作用
  • 批准号:
    10566127
    10566127
  • 财政年份:
    2022
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别:
Hox-Regulated MSCs in Skeletal Development, Growth and Fracture Healing
Hox 调节的 MSC 在骨骼发育、生长和骨折愈合中的作用
  • 批准号:
    10662574
    10662574
  • 财政年份:
    2022
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别:
Lipid Metabolism-driven Drug Resistance in Multiple Myeloma
脂质代谢驱动的多发性骨髓瘤耐药性
  • 批准号:
    10334473
    10334473
  • 财政年份:
    2021
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别:
Different consequences of cellular aging in cortical versus cancellous bone- Resubmission
皮质骨与松质骨细胞老化的不同后果 - Resubmission
  • 批准号:
    10208477
    10208477
  • 财政年份:
    2021
  • 资助金额:
    $ 39.5万
    $ 39.5万
  • 项目类别: